adamantane has been researched along with az10606120 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Khadra, A; Li, S; Sherman, A; Stojilkovic, SS; Tomic, M; Yan, Z | 1 |
| Marks, DC; Mullany, PR; Sluyter, R; Sophocleous, RA; Winter, KM | 1 |
| Giannuzzo, A; Novak, I; Pedersen, SF | 1 |
| Araújo, MGL; Fernandes, MJS; Franke, H; Gao, P; Illes, P; Khan, MT; Krügel, U; Liu, J; Rong, W; Rozmer, K; Tang, Y | 1 |
| Alves, F; Ellegaard, M; Giannuzzo, A; Napp, J; Novak, I; Saccomano, M | 1 |
| Sluyter, R; Vine, KL | 1 |
| Allsopp, RC; Dayl, S; Evans, RJ; Schmid, R | 1 |
| da Cunha-Bang, S; Dam, VH; Hjordt, LV; Knudsen, GM; Sestoft, D; Stenbæk, DS | 1 |
| Ettrup, A; Farde, L; Finnema, SJ; Halldin, C; Knudsen, GM; Martinsson, S; Stepanov, V; Takano, A; Yang, KC | 1 |
| Negulyaev, Y; Pugovkina, N; Semenova, S; Shamatova, M; Shatrova, A; Vassilieva, I | 1 |
| Dunay, IR; Hörauf, JA; Janicova, A; Kany, S; Martin, L; Relja, B; Sturm, R; Vrdoljak, T; Xu, B | 1 |
| Drummond, KJ; Kan, LK; Monif, M; O'Brien, TJ; Seneviratne, S; Williams, DA | 1 |
| Drill, M; Hamilton, JA; Jones, NC; Kan, LK; Monif, M; O'Brien, TJ; Powell, KL | 1 |
| Drill, M; Drummond, KJ; Galea, E; Hunn, M; Jayakrishnan, PC; Kan, LK; Monif, M; O'Brien, TJ; Sanfilippo, PG; Sequeira, RP; Todaro, M; Williams, DA | 1 |
14 other study(ies) available for adamantane and az10606120
| Article | Year |
|---|---|
Experimental characterization and mathematical modeling of P2X7 receptor channel gating.
Topics: Adamantane; Algorithms; Aminoquinolines; Animals; Calcium; Cells, Cultured; Electrophysiology; Humans; Ion Channel Gating; Kinetics; Markov Chains; Models, Neurological; Models, Statistical; Nonlinear Dynamics; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Transfection | 2010 |
Propensity of red blood cells to undergo P2X7 receptor-mediated phosphatidylserine exposure does not alter during in vivo or ex vivo aging.
Topics: Adamantane; Adenosine Triphosphate; Aminoquinolines; Annexin A5; Azo Compounds; Benzenesulfonates; Blood Preservation; Cellular Senescence; Erythrocyte Membrane; Humans; Membrane Lipids; Osmotic Fragility; Phosphatidylserines; Purinergic P2X Receptor Antagonists; Pyridines; Pyridoxal Phosphate; Receptors, Purinergic P2X1; Receptors, Purinergic P2X7; Tetrazoles | 2015 |
The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
Topics: Adamantane; Adenosine Triphosphate; Aminoquinolines; Apoptosis; Carcinoma, Pancreatic Ductal; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Pyridines; Receptors, Purinergic P2X7; Tetrazoles | 2015 |
Pilocarpine-Induced Status Epilepticus Increases the Sensitivity of P2X7 and P2Y1 Receptors to Nucleotides at Neural Progenitor Cells of the Juvenile Rodent Hippocampus.
Topics: Adamantane; Adenosine Triphosphate; Aminoquinolines; Animals; Disease Models, Animal; Excitatory Amino Acid Agents; Female; Gene Expression Regulation; Green Fluorescent Proteins; Hippocampus; Male; Membrane Potentials; Mice; Mice, Transgenic; Muscarinic Agonists; Neural Stem Cells; Nucleotides; Pilocarpine; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Receptors, Purinergic P2Y1; Status Epilepticus | 2017 |
Targeting of the P2X7 receptor in pancreatic cancer and stellate cells.
Topics: Adamantane; Aminoquinolines; Animals; Carcinoma, Pancreatic Ductal; Cell Growth Processes; Cell Line, Tumor; Heterografts; Humans; Luminescent Measurements; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Pancreatic Neoplasms; Pancreatic Stellate Cells; Receptors, Purinergic P2X7 | 2016 |
N-Alkyl-Substituted Isatins Enhance P2X7 Receptor-Induced Interleukin-1β Release from Murine Macrophages.
Topics: Adamantane; Aminoquinolines; Animals; Cell Line; Interleukin-1beta; Isatin; Macrophages; Mice; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7 | 2016 |
Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
Topics: Adamantane; Adenosine Triphosphate; Alleles; Allosteric Regulation; Allosteric Site; Amino Acid Sequence; Amino Acid Substitution; Aminoquinolines; Binding Sites; Humans; Ion Channel Gating; Lignans; Models, Molecular; Molecular Conformation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Structure-Activity Relationship | 2017 |
Anterior cingulate serotonin 1B receptor binding is associated with emotional response inhibition.
Topics: Adamantane; Adult; Aminoquinolines; Emotions; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Iodine Isotopes; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Personality Disorders; Photic Stimulation; Positron-Emission Tomography; Protein Binding; Receptor, Serotonin, 5-HT1B; Violence; Young Adult | 2017 |
Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain.
Topics: Adamantane; Aminoquinolines; Animals; Benzylamines; Brain; Brain Mapping; Dose-Response Relationship, Drug; Female; Fenfluramine; Fluorobenzenes; Macaca mulatta; Magnetic Resonance Imaging; Phenethylamines; Piperidines; Positron-Emission Tomography; Protein Binding; Purinergic P2X Receptor Antagonists; Receptor, Serotonin, 5-HT2A; Serotonin Agents | 2017 |
Adenosine-5'-triphosphate suppresses proliferation and migration capacity of human endometrial stem cells.
Topics: Adamantane; Adenosine Triphosphate; Aminoquinolines; Cell Movement; Cell Proliferation; Endometrium; Female; Gene Expression Regulation, Developmental; Humans; Mesenchymal Stem Cells; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Receptors, Purinergic P2Y; Regeneration | 2020 |
Short Exposure to Ethanol Diminishes Caspase-1 and ASC Activation in Human HepG2 Cells In Vitro.
Topics: Adamantane; Amino Acid Chloromethyl Ketones; Aminoquinolines; Caspase 1; Ethanol; Hep G2 Cells; Humans; Inflammasomes; Lipopolysaccharides; Liver; Reactive Oxygen Species; Vanadates | 2020 |
P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
Topics: Adamantane; Aminoquinolines; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Microglia; Microscopy, Confocal; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Signal Transduction; Tumor Microenvironment | 2020 |
Inhibition of purinergic P2X receptor 7 (P2X7R) decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) expression in U251 glioblastoma cells.
Topics: Adamantane; Aminoquinolines; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioblastoma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7 | 2020 |
P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastoma.
Topics: Adamantane; Aminoquinolines; Glioblastoma; Humans; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Temozolomide; Tumor Microenvironment | 2023 |